|
|
| March 29, 2020: Dr. William R. Hiatt and Dr. C. Michael Gibson Discuss: The Benefit And Risk Of Rivaroxaban Plus Aspirin In Patients Wit |
Dr. William R. Hiatt and Dr. C. Michael Gibson Discuss: The Benefit And Risk Of
Rivaroxaban Plus Aspirin In Patients With Peripheral Artery Disease After Lower Extremity
Revascularization (ler) With And Without Concomitant Clopidogrel: A Key Subgroup Analysis
From Voyager-pad
TBA
[ Download video ] |
|
No comments have been submitted
|